Long-Acting Beta-Agonists and Asthma Death: How Useful Are Different Study Designs to Evaluate the Potential Association?

By Weatherall Mark   Wijesinghe Meme   Perrin Kyle   Beasley Richard  

Journal of Asthma, Vol. 47, Iss. 4, 2010-05 ,pp. : 434-438

Informa Healthcare

Access to resources Recommend Favorite

Asthma Mortality and Long-Acting Beta2-Agonists in Five Major European Countries, 1994-2004

By Chatenoud Liliane   Malvezzi Matteo   Pitrelli Andrea   La Vecchia Carlo   Bamfi Francesco  

Journal of Asthma, Vol. 46, Iss. 6, 2009-08 ,pp. : 546-551

Informa Healthcare

Access to resources Recommend Favorite

Survival with Tiotropium Compared to Long-Acting Beta-2-Agonists in Chronic Obstructive Pulmonary Disease

By Gershon Andrea   Wang Li   To Teresa   Luo Jin   Upshur Ross  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 5, Iss. 4, 2008-08 ,pp. : 229-234

Informa Healthcare

Access to resources Recommend Favorite

Long-Acting -Agonists: Comparative Pharmacology and Clinical Outcomes

By van der Woude H.J.   Aalbers R.  

American Journal of Respiratory Medicine, Vol. 1, Iss. 1, 2002-01 ,pp. : 55-74

Adis International

Access to resources Recommend Favorite

Inhaled Corticosteroids With/Without Long-Acting -Agonists Reduce the Risk of Rehospitalization and Death in COPD Patients

By Soriano J.B.  

American Journal of Respiratory Medicine, Vol. 2, Iss. 1, 2003-01 ,pp. : 67-74

Adis International

Access to resources Recommend Favorite